3.715
price up icon2.91%   0.105
after-market Dopo l'orario di chiusura: 3.72 0.005 +0.13%
loading
Precedente Chiudi:
$3.61
Aprire:
$3.6
Volume 24 ore:
403.17K
Relative Volume:
0.43
Capitalizzazione di mercato:
$116.23M
Reddito:
-
Utile/perdita netta:
$-29.25M
Rapporto P/E:
-3.1324
EPS:
-1.186
Flusso di cassa netto:
$-22.80M
1 W Prestazione:
-9.83%
1M Prestazione:
-13.81%
6M Prestazione:
+26.79%
1 anno Prestazione:
-41.86%
Intervallo 1D:
Value
$3.56
$3.73
Intervallo di 1 settimana:
Value
$3.55
$4.18
Portata 52W:
Value
$2.39
$7.41

Sagimet Biosciences Inc Stock (SGMT) Company Profile

Name
Nome
Sagimet Biosciences Inc
Name
Telefono
(650) 561-8600
Name
Indirizzo
155 BOVET RD., SUITE 303, SAN MATEO
Name
Dipendente
10
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SGMT's Discussions on Twitter

Confronta SGMT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SGMT
Sagimet Biosciences Inc
3.715 116.23M 0 -29.25M -22.80M -1.186
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
479.79 121.85B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
698.74 76.83B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
624.67 37.96B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.75 30.69B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
271.80 29.71B 3.32B -860.46M -1.04B -8.32

Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-06 Iniziato Oppenheimer Outperform
2024-11-12 Iniziato UBS Buy
2024-06-28 Downgrade Goldman Buy → Neutral
2024-05-02 Iniziato H.C. Wainwright Buy
2024-03-25 Iniziato Leerink Partners Outperform
2023-08-08 Iniziato Goldman Buy
2023-08-08 Iniziato JMP Securities Mkt Outperform
2023-08-08 Iniziato Piper Sandler Overweight
2023-08-08 Iniziato TD Cowen Outperform
Mostra tutto

Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie

pulisher
Feb 25, 2025

Is Sagimet Biosciences Inc. (SGMT) the Best Get Rich Quick Stock to Invest In? - Insider Monkey

Feb 25, 2025
pulisher
Feb 24, 2025

10 Best Get Rich Quick Stocks To Invest In - Insider Monkey

Feb 24, 2025
pulisher
Feb 23, 2025

Brokerages Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $23.00 - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

10 Hot Penny Stocks to Buy Now - Insider Monkey

Feb 22, 2025
pulisher
Feb 22, 2025

Unveiling Hidden Gems: The Hot Penny Stock You Might Be Missing - Reporteros del Sur -

Feb 22, 2025
pulisher
Feb 22, 2025

Sagimet Biosciences Inc. (SGMT): Among the Hot Penny Stocks to Buy Now - Insider Monkey

Feb 22, 2025
pulisher
Feb 21, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 21, 2025
pulisher
Feb 19, 2025

Sagimet Biosciences Announces Oral Presentation at the MASH - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic ... - The Bakersfield Californian

Feb 19, 2025
pulisher
Feb 19, 2025

Could This New MASH Drug Transform Liver Disease Treatment? Key Phase 2b Results Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 14, 2025

FY2024 Earnings Estimate for SGMT Issued By Leerink Partnrs - MarketBeat

Feb 14, 2025
pulisher
Feb 11, 2025

Technical analysis of Sagimet Biosciences Inc (SGMT) stock chart patterns - US Post News

Feb 11, 2025
pulisher
Feb 11, 2025

FY2024 Earnings Forecast for SGMT Issued By Leerink Partnrs - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Keeping an Eye on Sagimet Biosciences Inc (SGMT) After Insider Trading Activity - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Sagimet Biosciences Inc (NASDAQ:SGMT) Up 47.7% Since 52-Week Low; YTD Rose 1.56% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Equities Analysts Issue Forecasts for SGMT FY2029 Earnings - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Prepare Yourself for Liftoff: Sagimet Biosciences Inc (SGMT) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Sagimet Biosciences Inc (SGMT)’s results reveal risk - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Analytical Overview: Sagimet Biosciences Inc (SGMT)’s Ratios Tell a Financial Story - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

US Penny Stocks Spotlight: Gevo And 2 Other Promising Picks - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

Buy Recommendation for Sagimet Biosciences: Denifanstat’s Unique Profile and Undervaluation Offer Compelling Investment Opportunity - TipRanks

Feb 03, 2025
pulisher
Feb 02, 2025

What's Going On With Sagimet Biosciences Stock On Thursday? - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

JPMorgan Chase & Co. Boosts Stake in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Feb 01, 2025
pulisher
Feb 01, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 01, 2025
pulisher
Jan 27, 2025

This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jan 27, 2025
pulisher
Jan 26, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jan 26, 2025
pulisher
Jan 24, 2025

Sagimet Stock Soars To 10-Month High, Retail’s Fired Up Over Presentation On Lead MASH Drug Candidate - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Barclays PLC Has $159,000 Stock Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jan 23, 2025
pulisher
Jan 20, 2025

With 43% stake, Sagimet Biosciences Inc. (NASDAQ:SGMT) seems to have captured institutional investors' interest - Simply Wall St

Jan 20, 2025
pulisher
Jan 13, 2025

Sagimet Biosciences' SWOT analysis: promising NASH drug faces funding hurdles - Investing.com

Jan 13, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Acquires 91,246 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

When (SGMT) Moves Investors should Listen - Stock Traders Daily

Jan 12, 2025
pulisher
Jan 10, 2025

Gaining Ground: Sagimet Biosciences Inc (SGMT) Closes Lower at 5.37, Down -3.59 - The Dwinnex

Jan 10, 2025
pulisher
Jan 08, 2025

Barclays PLC Boosts Stock Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jan 08, 2025
pulisher
Jan 06, 2025

Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Sagimet to Present Breakthrough MASH Treatment Data at MASH-TAG Conference 2025 - StockTitan

Jan 06, 2025
pulisher
Jan 04, 2025

Sagimet Biosciences Updates Investor Presentation in Recent 8-K Filing - Defense World

Jan 04, 2025
pulisher
Jan 04, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $23.00 Average PT from Analysts - Defense World

Jan 04, 2025
pulisher
Jan 01, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 01, 2025
pulisher
Dec 29, 2024

Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Dec 29, 2024
pulisher
Dec 21, 2024

(SGMT) Trading Advice - Stock Traders Daily

Dec 21, 2024
pulisher
Dec 17, 2024

Sagimet Biosciences: A Rising Star in the Fight Against NASH with Promising Clinical Data for Denifanstat - mediahousepress

Dec 17, 2024

Sagimet Biosciences Inc Azioni (SGMT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Sagimet Biosciences Inc Azioni (SGMT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Martins Eduardo Bruno
Chief Medical Officer
Jul 19 '24
Sale
3.10
8,357
25,910
81,213
Rozek Elizabeth
General Counsel and CCO
Jul 19 '24
Sale
3.10
10,914
33,830
160,506
Kemble George
Executive Chairman
Jul 19 '24
Sale
3.10
14,062
43,605
142,318
Happel David
President & CEO
Mar 26 '24
Buy
5.27
12,100
63,731
639,200
$81.55
price up icon 2.95%
$22.68
price down icon 0.31%
$33.64
price up icon 0.63%
$319.86
price down icon 1.18%
$113.03
price up icon 3.89%
biotechnology ONC
$271.80
price down icon 2.56%
Capitalizzazione:     |  Volume (24 ore):